NASDAQ : CODX
Co-Diagnostics, Inc. — Financial statements
Healthcare · Medical Devices · United States
Last price 0.3667 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 2.91M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Co-Diagnostics, Inc. (CODX) reported revenue of 721.39K USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Operating Revenue | 517.10K | 418.20K | 770.05K | 991.47K | 34.22M | 97.89M |
| Other Revenue | 204.28K | 204.28K | 3.15M | 5.82M | ||
| Revenue | 721.39K | 622.49K | 3.92M | 6.81M | 34.22M | 97.89M |
| Cost of Revenue | 407.75K | 222.38K | 999.12K | 4.18M | 5.48M | 11.57M |
| Gross Profit | 313.63K | 400.11K | 2.92M | 2.63M | 28.74M | 86.31M |
| Selling, General & Admin | 9.74M | 11.44M | 20.64M | 21.14M | 21.61M | 24.95M |
| Research & Development | 19.67M | 19.14M | 20.98M | 22.96M | 17.44M | 14.96M |
| Operating Expenses | 30.40M | 31.68M | 43.00M | 45.33M | 40.33M | 40.25M |
| Operating Income | -30.08M | -31.28M | -40.08M | -42.71M | -11.59M | 46.06M |
| Interest & Investment Income | 291.64K | 292.93K | 1.09M | 1.16M | 704.04K | 45.63K |
| Earnings From Equity Investments | -96.61K | -46.30K | -186.07K | 100.70K | -332.97K | -430.43K |
| EBT Excluding Unusual Items | -29.89M | -31.04M | -39.18M | -41.44M | -11.22M | 45.68M |
| Impairment of Goodwill | -15.39M | |||||
| Gain (Loss) on Sale of Investments | 41.54K | 683.37K | 870.75K | 2.24M | ||
| Gain (Loss) on Sale of Assets | -73.42K | -82.42K | 8.29K | -2.58K | -138.12K | -44.35K |
| Asset Writedown | -18.88M | -18.88M | ||||
| Other Unusual Items | 124.68K | 805.86K | 714.88K | 1.09M | 7.90M | |
| Pretax Income | -48.68M | -48.51M | -37.58M | -38.11M | -18.85M | 45.64M |
| Income Tax Expense | -1.62M | -1.62M | 57.37K | -2.78M | -4.61M | 8.98M |
| Net Income | -47.06M | -46.90M | -37.64M | -35.33M | -14.24M | 36.66M |
| Net Income to Common | -47.06M | -46.90M | -37.64M | -35.33M | -14.24M | 36.66M |
| Shares Outstanding (Basic) | 2.43M | 1.33M | 1.01M | 978.22K | 1.05M | 962.48K |
| Shares Outstanding (Diluted) | 2.43M | 1.33M | 1.01M | 978.22K | 1.05M | 996.79K |
| EPS (Basic) | -19.36 | -35.25 | -37.22 | -36.12 | -13.57 | 38.09 |
| EPS (Diluted) | -19.36 | -35.25 | -37.22 | -36.12 | -13.57 | 36.90 |
| Free Cash Flow | -27.47M | -29.84M | -29.90M | -23.45M | 5.14M | 40.41M |
| Free Cash Flow Per Share | -11.30 | -22.43 | -29.57 | -23.97 | 4.90 | 40.54 |
| Gross Margin | 43.48% | 64.28% | 74.48% | 38.56% | 83.98% | 88.17% |
| Operating Margin | -4,170.14% | -5,025.53% | -1,023.75% | -626.92% | -33.88% | 47.06% |
| Profit Margin | -6,523.05% | -7,533.62% | -961.37% | -518.68% | -41.61% | 37.45% |
| Free Cash Flow Margin | -3,808.03% | -4,793.17% | -763.79% | -344.20% | 15.02% | 41.28% |
| EBITDA | -29.09M | -30.18M | -38.70M | -41.48M | -10.31M | 46.40M |
| EBITDA Margin | -30.13% | 47.40% | ||||
| D&A For EBITDA | 992.23K | 1.11M | 1.38M | 1.23M | 1.28M | 335.36K |
| EBIT | -30.08M | -31.28M | -40.08M | -42.71M | -11.59M | 46.06M |
| EBIT Margin | -33.88% | 47.06% | ||||
| Effective Tax Rate | 19.67% | |||||
| Revenue as Reported | 721.39K | 622.49K | 3.92M | 6.81M | 34.22M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 3.65M | 11.88M | 2.94M | 14.92M | 22.97M | 88.61M |
| Short-Term Investments | 26.81M | 43.63M | 58.29M | 1.26M | ||
| Cash & Short-Term Investments | 3.65M | 11.88M | 29.75M | 58.55M | 81.26M | 89.86M |
| Accounts Receivable | 52.06K | 190.38K | 132.57K | 303.93K | 3.45M | 20.84M |
| Other Receivables | 425.00 | 44.56K | 26.95K | 1.87M | ||
| Receivables | 52.48K | 234.93K | 132.57K | 330.88K | 5.40M | 20.91M |
| Inventory | 841.67K | 992.40K | 1.07M | 1.66M | 5.31M | 2.00M |
| Prepaid Expenses | 648.67K | 581.53K | 1.34M | 1.60M | 761.19K | 2.34M |
| Total Current Assets | 5.19M | 13.69M | 32.29M | 62.14M | 92.73M | 115.12M |
| Property, Plant & Equipment | 3.74M | 3.48M | 4.88M | 6.00M | 2.91M | 1.93M |
| Long-Term Investments | 435.05K | 350.57K | 294.30K | 773.38K | 672.68K | 1.00M |
| Goodwill | 14.71M | |||||
| Other Intangible Assets | 7.22M | 7.22M | 26.10M | 26.40M | 26.77M | 27.20M |
| Total Assets | 16.59M | 24.74M | 63.56M | 95.32M | 123.09M | 160.03M |
| Accounts Payable | 1.08M | 1.88M | 3.29M | 1.48M | 952.30K | 607.51K |
| Accrued Expenses | 899.18K | 865.30K | 2.56M | 2.17M | 934.45K | 3.86M |
| Current Portion of Leases | 784.26K | 662.26K | 915.62K | 838.39K | 297.21K | |
| Current Income Taxes Payable | 2.21M | |||||
| Current Unearned Revenue | 28.64K | 14.80K | 40.86K | 362.45K | 150.00K | |
| Other Current Liabilities | 72.93K | 119.04K | 502.82K | 891.67K | 1.69M | 5.77M |
| Total Current Liabilities | 2.86M | 3.54M | 7.32M | 5.75M | 3.87M | 12.60M |
| Long-Term Leases | 1.01M | 574.30K | 1.24M | 2.15M | 50.71K | |
| Long-Term Deferred Tax Liabilities | 2.42M | 7.23M | ||||
| Other Long-Term Liabilities | 1.14M | 1.41M | 2.22M | 5.73M | ||
| Total Liabilities | 3.88M | 4.11M | 9.69M | 9.31M | 8.57M | 25.56M |
| Common Stock | 70.48K | 67.70K | 37.90K | 36.11K | 34.75K | 33.82K |
| Additional Paid-In Capital | 124.02M | 116.51M | 102.47M | 96.81M | 88.47M | 80.27M |
| Retained Earnings | -95.80M | -80.37M | -33.48M | 4.60M | 39.93M | 54.17M |
| Treasury Stock | -15.58M | -15.58M | -15.58M | -15.58M | -14.21M | |
| Comprehensive Income & Other | 418.44K | 146.70K | 293.14K | |||
| Total Common Equity | 12.71M | 20.63M | 53.88M | 86.01M | 114.52M | 134.48M |
| Shareholders' Equity | 12.71M | 20.63M | 53.88M | 86.01M | 114.52M | 134.48M |
| Total Liabilities & Equity | 16.59M | 24.74M | 63.56M | 95.32M | 123.09M | 160.03M |
| Total Debt | 1.80M | 1.24M | 2.15M | 2.99M | 347.92K | |
| Net Cash (Debt) | 1.85M | 10.65M | 27.60M | 55.56M | 80.91M | 89.86M |
| Net Cash Per Share | 0.76 | 8.00 | 27.29 | 56.79 | 77.11 | 90.15 |
| Filing Date Shares Outstanding | 6.25M | 3.60M | 1.12M | 1.04M | 1.03M | 1.13M |
| Total Common Shares Outstanding | 4.88M | 2.10M | 1.10M | 1.04M | 1.03M | 1.13M |
| Working Capital | 2.33M | 10.15M | 24.98M | 56.39M | 88.86M | 102.52M |
| Book Value Per Share | 2.61 | 9.85 | 48.90 | 82.55 | 111.28 | 119.29 |
| Tangible Book Value | 5.49M | 13.41M | 27.77M | 59.61M | 87.75M | 92.57M |
| Tangible Book Value Per Share | 1.13 | 6.40 | 25.21 | 57.21 | 85.27 | 82.12 |
| Machinery | 5.21M | 5.09M | 4.72M | 3.69M | 2.55M | |
| Leasehold Improvements | 968.57K | 947.67K | 548.65K | 224.96K | 3.16K |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -47.06M | -46.90M | -37.64M | -35.33M | -14.24M | 36.66M |
| Depreciation & Amortization | 992.23K | 1.11M | 1.38M | 1.23M | 1.28M | 335.36K |
| Loss (Gain) From Sale of Assets | 73.42K | 82.42K | -8.29K | 2.58K | 138.12K | 44.35K |
| Asset Writedown & Restructuring Costs | 18.88M | 18.88M | 15.39M | |||
| Loss (Gain) From Sale of Investments | -41.54K | -683.37K | -870.75K | -2.24M | ||
| Loss (Gain) on Equity Investments | 96.61K | 46.30K | 186.07K | -100.70K | 332.97K | 430.43K |
| Stock-Based Compensation | 1.09M | 2.25M | 5.43M | 8.34M | 7.54M | 5.51M |
| Provision & Write-off of Bad Debts | -12.20K | -26.01K | -15.04K | 612.81K | 2.46M | 69.67K |
| Other Operating Activities | -9.70K | -730.00K | -374.85K | -229.29K | -12.53M | 930.08K |
| Change in Accounts Receivable | 171.11K | -31.80K | 186.39K | 2.54M | 14.92M | -8.74M |
| Change in Inventory | 257.81K | 131.27K | 265.49K | 413.14K | -3.67M | 5.71M |
| Change in Accounts Payable | -665.76K | -3.11M | 2.16M | 1.77M | -2.48M | -299.94K |
| Change in Unearned Revenue | -17.21K | -26.06K | -321.59K | 362.45K | -150.00K | -155.31K |
| Change in Income Taxes | -736.93K | -713.64K | 54.46K | -522.10K | -2.20M | 2.64M |
| Change in Other Net Operating Assets | -127.10K | 585.93K | 412.06K | 1.08M | -224.09K | -2.05M |
| Operating Cash Flow | -27.10M | -29.14M | -29.16M | -22.08M | 6.57M | 41.08M |
| Capital Expenditures | -367.37K | -700.05K | -748.35K | -1.37M | -1.43M | -669.46K |
| Cash Acquisitions | 1.20M | |||||
| Investment in Securities | 1.90M | 26.97M | 17.82M | 16.75M | -56.74M | 3.57M |
| Investing Cash Flow | 1.54M | 26.27M | 17.07M | 15.39M | -58.17M | 4.10M |
| Issuance of Common Stock | 18.10M | 11.81M | 103.91K | 177.87K | 450.40K | |
| Repurchase of Common Stock | -1.36M | -14.21M | ||||
| Financing Cash Flow | 18.10M | 11.81M | 103.91K | -1.36M | -14.03M | 450.40K |
| Net Cash Flow | -7.47M | 8.95M | -11.98M | -8.06M | -65.63M | 45.63M |
| Free Cash Flow | -27.47M | -29.84M | -29.90M | -23.45M | 5.14M | 40.41M |
| Free Cash Flow Margin | -3,808.03% | -4,793.17% | -763.79% | -344.20% | 15.02% | 41.28% |
| Free Cash Flow Per Share | -11.30 | -22.43 | -29.57 | -23.97 | 4.90 | 40.54 |
| Levered Free Cash Flow | -17.49M | -19.68M | -16.45M | -9.28M | 4.92M | 37.74M |
| Unlevered Free Cash Flow | -17.49M | -19.68M | -16.45M | -9.28M | 4.92M | 37.74M |
| Cash Income Tax Paid | 832.28K | 858.87K | 55.98K | 4.50M | 5.40M | |
| Change in Working Capital | -1.12M | -3.17M | 2.75M | 5.64M | 6.19M | -2.90M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 2.91M | 10.27M | 23.95M | 40.67M | 77.91M | 260.40M |
| Enterprise Value | 1.06M | 294.64K | -11.35M | -19.71M | -8.16M | 176.49M |
| Last Close Price | 0.37 | 5.06 | 22.50 | 39.90 | 75.60 | 267.90 |
| PE Ratio | 7.10 | |||||
| Forward PE | 47.18 | 47.18 | 47.18 | 47.18 | 26.93 | |
| PS Ratio | 4.04 | 16.49 | 6.12 | 5.97 | 2.28 | 2.66 |
| PB Ratio | 0.14 | 0.50 | 0.44 | 0.47 | 0.68 | 1.94 |
| P/TBV Ratio | 0.53 | 0.77 | 0.86 | 0.68 | 0.89 | 2.81 |
| P/FCF Ratio | 15.15 | 6.44 | ||||
| P/OCF Ratio | 11.86 | 6.34 | ||||
| PEG Ratio | 1.89 | 1.89 | 1.89 | 1.89 | 1.08 | |
| EV/Sales Ratio | 1.47 | 0.47 | 1.80 | |||
| EV/EBITDA Ratio | 3.80 | |||||
| EV/EBIT Ratio | 3.83 | |||||
| EV/FCF Ratio | 4.37 | |||||
| Debt / Equity Ratio | 0.14 | 0.06 | 0.04 | 0.04 | 0.00 | |
| Debt / FCF Ratio | 0.07 | |||||
| Net Debt / Equity Ratio | -0.15 | -0.52 | -0.51 | -0.65 | -0.71 | -0.67 |
| Net Debt / EBITDA Ratio | 0.06 | 0.35 | 0.71 | 1.34 | 7.85 | -1.94 |
| Net Debt / FCF Ratio | 0.07 | 0.36 | 0.92 | 2.37 | -15.74 | -2.22 |
| Asset Turnover | 0.02 | 0.01 | 0.05 | 0.06 | 0.24 | 0.85 |
| Inventory Turnover | 0.42 | 0.21 | 0.73 | 1.20 | 1.50 | 2.31 |
| Quick Ratio | 1.29 | 3.42 | 4.08 | 10.24 | 22.35 | 8.79 |
| Current Ratio | 1.81 | 3.87 | 4.41 | 10.81 | 23.94 | 9.14 |
| Return on Equity (ROE) | -174.77% | -125.89% | -53.81% | -35.24% | -11.44% | 36.45% |
| Return on Assets (ROA) | -59.64% | -44.28% | -31.53% | -24.44% | -5.12% | 24.90% |
| Return on Invested Capital (ROIC) | -290.60% | -172.55% | -141.29% | -133.33% | -29.64% | 115.64% |
| Return on Capital Employed (ROCE) | -219.10% | -147.50% | -71.30% | -47.70% | -9.70% | 31.20% |
| Earnings Yield | -5,278.90% | -456.79% | -157.17% | -86.87% | -18.27% | 14.08% |
| FCF Yield | -942.62% | -290.62% | -124.87% | -57.65% | 6.60% | 15.52% |
| Buyback Yield / Dilution | -130.53% | -31.55% | -3.37% | 6.77% | -5.27% | -6.80% |